Emesis induced by low or minimal emetic risk chemotherapy

Supportive Care in Cancer

Volumn 13, Issue 2, 2005, Pages 109-111

  Tonato, Maurizio ^a   Clark Snow, Rebecca A ^b   Osoba, David ^c   Del Favero, Albano ^d   Ballatori, Enzo ^d   Borjeson, Sussanne ^e  

^a Policlinico Hospital   (Italy)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^c University of Perugia ^*

^d UNIVERSITY OF L'AQUILA   (Italy)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Low emetogenic chemotherapy; Minimal emetogenic chemotherapy

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BENZAMIDE; CAPECITABINE; CORTICOSTEROID; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; METOCLOPRAMIDE; PHENOTHIAZINE; SEROTONIN 3 ANTAGONIST; TAXANE DERIVATIVE;

CANCER CHEMOTHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; HUMAN; NAUSEA AND VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; PRACTICE GUIDELINES; VOMITING;

EID: 17644370041     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0703-5     Document Type: Review

References (6)

1. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy and radiotherapy-induced emesis: results of the Perugia Consensus Conference. Ann Oncol 9:811-819
2. DeAngelis V, Roila F, Sabbatini R, et al (2003) Cancer chemotherapy-induced delayed emesis: antiemetic prescriptions in clinical practice. ASCO abstract 2971
3. Gralla R, Osoba D, Kris M, et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971-2994
4. Italian Group for Antiemetic Research (1998) Transferability to clinical practice of the clinical results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Ann Oncol 9:759-765
5. Italian Group for Antiemetic Research (2001) Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study. Tumori 87:379-382
6. Roila F (2004) Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions. Support Care Cancer 12:446-453